
UQ begins first human trial of immunotherapy for Type 1 diabetes
Researchers at The University of Queensland have dosed 5 participants in the first clinical trial of a potentially revolutionary immunotherapy drug to treat Type 1 diabetes. Professor Ranjeny Thomas AM from UQ's Frazer Institute has led the development …